GT Biopharma, Inc. (GTBP)
0.299
-0.01
(-2.22%)
USD |
NASDAQ |
Aug 25, 16:00
0.299
0.00 (0.00%)
After-Hours: 19:11
GT Biopharma Price to Book Value : 3.743 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.828 |
| August 21, 2026 | 3.613 |
| August 20, 2026 | 3.530 |
| August 19, 2026 | 3.592 |
| August 18, 2026 | 3.448 |
| August 17, 2026 | 3.568 |
| August 14, 2026 | 3.706 |
| August 13, 2026 | 3.723 |
| August 12, 2026 | 3.782 |
| August 11, 2026 | 3.916 |
| August 10, 2026 | 4.014 |
| August 07, 2026 | 4.007 |
| August 06, 2026 | 3.768 |
| August 05, 2026 | 3.975 |
| August 04, 2026 | 4.082 |
| August 03, 2026 | 3.863 |
| July 31, 2026 | 3.674 |
| July 30, 2026 | 3.853 |
| July 29, 2026 | 3.778 |
| July 28, 2026 | 3.965 |
| July 27, 2026 | 4.182 |
| July 24, 2026 | 4.060 |
| July 23, 2026 | 4.196 |
| July 22, 2026 | 4.326 |
| July 21, 2026 | 4.485 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.269 |
| July 17, 2026 | 4.455 |
| July 16, 2026 | 4.801 |
| July 15, 2026 | 4.386 |
| July 14, 2026 | 4.619 |
| July 13, 2026 | 4.854 |
| July 10, 2026 | 5.320 |
| July 09, 2026 | 5.598 |
| July 08, 2026 | 5.854 |
| July 07, 2026 | 5.759 |
| July 06, 2026 | 6.132 |
| July 02, 2026 | 5.906 |
| July 01, 2026 | 6.184 |
| June 30, 2026 | 6.130 |
| June 29, 2026 | 2.042 |
| June 26, 2026 | 1.996 |
| June 25, 2026 | 1.932 |
| June 24, 2026 | 2.117 |
| June 23, 2026 | 2.292 |
| June 22, 2026 | 2.277 |
| June 18, 2026 | 2.386 |
| June 17, 2026 | 2.131 |
| June 16, 2026 | 2.069 |
| June 15, 2026 | 2.176 |
| June 12, 2026 | 2.075 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.029 |
| Alnylam Pharmaceuticals, Inc. | 23.70 |
| Anika Therapeutics, Inc. | 2.098 |
| Savara, Inc. | 7.992 |
| Vericel Corp. | 5.970 |
Price to Book Value Related Metrics
| Price | 0.299 |
| Earnings Yield | -1.20K% |
| Market Cap | 13.36M |